- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06169969
Effect Of Magnetic Therapy In Bladder Dysfunction And Quality Of Life In Paraplegic Patients
March 4, 2024 updated by: Moataz Mohamed Talaat El Semary, Cairo University
Effect of Magnetic Therapy in Bladder Dysfunction and Quality of Life in Paraplegic Patients
Each study subject will undergo baseline urodynamic testing (UDS) at the beginning of the study to confirm the diagnosis of a neurogenic bladder with DSD and establish baseline bladder functions.
The study will be divided into two phases: a Treatment phase (16 weeks) and a Follow-up phase (6 weeks).
During the treatment phase, each subject will undergo once/week magnetic spinal cord stimulation (MSCS) at 1Hz (low) frequency (40-60% intensity) over the lumbar spine.
Once each subject entered the treatment phase of the study and will receive weekly lumbar spinal cord magnetic stimulation for a total of 16 weeks.
This 16-week period of MSCS constituted bladder rehabilitation.
Each subject will receive non-video urodynamic testing once every four weeks during the treatment phase to monitor progress and ensure that bladder function will not further impaired.
After the initial four-week stimulation period, each subject will be asked to attempt volitional urination for 5-10minutes prior to bladder catheterization.
the subjects will instruct to keep the environment quiet, relax and focus on voiding
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Forty male Paraplegic patients will be recruited.…from
outpatients' clinics and their ages from 20 to 35 years and the inclusion criteria for the study will be a stable American Spinal Injury Association Impairment Scale (AISA) A/B, motor complete spinal cord injury between spinal levels T6-T12 present for greater than 1 year, and a documented history of neurogenic bladder requiring intermittent catheterization.
Each subject will require to have at least three prior urodynamic studies to confirm the diagnosis of neurogenic bladder with detrusor sphincter dyssynergia (DSD), which was diagnosed with urodynamic study in which a rise in detrusor pressure and concomitant needle EMG activity and rise in urethral pressure were demonstrated Patients with a history of autonomic dysreflexia were excluded from the study.
Any patient who will be ventilator dependent, abusing drugs, have musculoskeletal dysfunction (i.e., unstable fractures), cardiopulmonary diseases, active infections or ongoing depression requiring treatment, or have previous exposure to and use of spinal cord stimulation will be excluded from the study.
Patients with a history of bladder Botox injection or bladder/sphincter surgeries will be excluded
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Cairo, Egypt
- Faculty of physical therapy
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Description
IInclusion Criteria:
- Male Participants ages 20 to 35 years
- Participants will be a stable American Spinal Injury Association Impairment Scale (AISA) A/B.
- Motor incomplete spinal cord injury between spinal levels T6-T12.
- Participants present for more than 1 year.
- Each participant will require at least three prior urodynamic studies to confirm the diagnosis of neurogenic bladder with detrusor sphincter dyssynergia (DSD), which was diagnosed with urodynamic study.
Exclusion Criteria:
- Patients with a history of autonomic dysreflexia.
- Any patient who will be ventilator dependent, abusing drugs, have musculoskeletal dysfunction (i.e., unstable fractures).
- Any patient who will have cardiopulmonary diseases, active infections or ongoing depression requiring treatment, or have previous exposure to and use of spinal cord stimulation.
- Patients with a history of bladder Botox injection or bladder/sphincter surgeries.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Magnetic therapy group
receive magnetic therapy plus pelvic floor exercises.
|
Kegel exercises
Other Names:
|
No Intervention: Pelvic floor exercises group
pelvic floor exercises only
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Bladder Volume at first desire to void in Milliliters.
Time Frame: Baseline, pre-intervention then Peri procedurally after 8 weeks and finally "immediately after the intervention (16 weeks)
|
one of bladder functions using urodynamic testing
|
Baseline, pre-intervention then Peri procedurally after 8 weeks and finally "immediately after the intervention (16 weeks)
|
Detrusor pressure At Qmax in Centimeters of water
Time Frame: Baseline, pre-intervention then Peri procedurally after 8 weeks and finally "immediately after the intervention (16 weeks)
|
one of bladder functions using urodynamic testing
|
Baseline, pre-intervention then Peri procedurally after 8 weeks and finally "immediately after the intervention (16 weeks)
|
Maximum flow rate in milliliters per second
Time Frame: Baseline, pre-intervention then Peri procedurally after 8 weeks and finally "immediately after the intervention (16 weeks)
|
one of bladder functions using urodynamic testing
|
Baseline, pre-intervention then Peri procedurally after 8 weeks and finally "immediately after the intervention (16 weeks)
|
Amplitude per time in millivolts
Time Frame: Baseline, pre-intervention then Peri procedurally after 8 weeks and finally "immediately after the intervention (16 weeks)
|
EMG Measurement during contraction of pelvic floor muscles
|
Baseline, pre-intervention then Peri procedurally after 8 weeks and finally "immediately after the intervention (16 weeks)
|
Upper centile amplitude in millivolts
Time Frame: Baseline, pre-intervention then Peri procedurally after 8 weeks and finally "immediately after the intervention (16 weeks)
|
EMG Measurement during contraction of pelvic floor muscles
|
Baseline, pre-intervention then Peri procedurally after 8 weeks and finally "immediately after the intervention (16 weeks)
|
Qualiveen short version 8 questions from 1 to 4 (worse if high score)
Time Frame: Baseline, pre-intervention then Peri procedurally after 8 weeks and finally "immediately after the intervention (16 weeks)
|
Qualiveen questionnaire short form of quality of life
|
Baseline, pre-intervention then Peri procedurally after 8 weeks and finally "immediately after the intervention (16 weeks)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 5, 2023
Primary Completion (Actual)
February 21, 2024
Study Completion (Actual)
March 4, 2024
Study Registration Dates
First Submitted
November 19, 2023
First Submitted That Met QC Criteria
December 5, 2023
First Posted (Actual)
December 14, 2023
Study Record Updates
Last Update Posted (Estimated)
March 5, 2024
Last Update Submitted That Met QC Criteria
March 4, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- P.T.REC/012/004741
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Spinal Cord Injuries
-
Khon Kaen UniversityUnknownInjuries, Spinal Cord
-
Universidade do Vale do ParaíbaCompletedInjuries, Spinal Cord
-
InVivo TherapeuticsTerminated
-
Ekso BionicsBurke Medical Research InstituteCompletedInjuries, Spinal CordUnited States
-
ReWalk Robotics, Inc.Unknown
-
Shepherd Center, Atlanta GACompletedInjuries, Spinal Cord
-
M.D. Anderson Cancer CenterActive, not recruitingMetastatic Epidural Spinal Cord CompressionUnited States
-
Wroclaw Medical UniversityInstitute of Immunology and Experimental Therapy of the Polish Academy of... and other collaboratorsUnknownComplete Spinal Cord InjuriesPoland
Clinical Trials on magnetic therapy
-
pico-tesla Magnetic Therapies, LLCCompletedFibromyalgia
-
Wave NeuroscienceCompletedStress Disorders, Post-TraumaticUnited States
-
Ankara City Hospital BilkentNot yet recruiting
-
Auburn UniversityQuantumTX Pte LtdRecruiting
-
King Fahad Armed Forces HospitalImam Abdulrahman Bin Faisal UniversityCompletedSpastic Cerebral Palsy
-
Universidad Complutense de MadridNot yet recruiting
-
Hospital San Carlos, MadridActive, not recruitingAlzheimer Disease | Frontotemporal Dementia | Primary Progressive AphasiaSpain
-
72nd Medical Group, Tinker Air Force Basebrain treatment center; MacDill AFBTerminatedPost-Traumatic Stress DisordersUnited States
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityRecruitingIntracranial NeoplasmUnited States
-
University of Alabama at BirminghamNIH National Rehabilitation Research Resource to Enhance Clinical TrialsTerminatedStroke | Hemiplegia | HemiparesisUnited States